About Index Trending news
Lists
Pricing
Retrophin

Retrophin

Retrophin

Retrophin is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of catastrophic diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO debt
$45,000,000
Convertible Note
$46,000,000
Employees

Team size

50+
Locations
HQ
Xconomy

Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results

Health
The Motley Fool

Why Retrophin Inc was Down Today

Health Stock markets
The Motley Fool

Why Retrophin's Shares Are Crashing Today --

Technology Stock markets